NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

RecruitingPhase 4

Sponsor: University of Alabama at Birmingham

Conditions: Vaccine, Pneumococcal Disease

Interventions: Pneumococcal Vaccine

Countries: United States

The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria. We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Healthy adult

Exclusion Criteria:

* No prior history of pneumococcal vaccination
* No immunosuppressing medications or chronic diseases that affect immune function

Locations (1)

Birmingham, Alabama, United States